VAIGHT Trademark
Trademark Overview
On Wednesday, July 31, 2019, a trademark application was filed for VAIGHT with the United States Patent and Trademark Office. The USPTO has given the VAIGHT trademark a serial number of 88554942. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 20, 2023. This trademark is owned by Eli Lilly and Company. The VAIGHT trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, headaches, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, neurodegenerative diseases and disorders, neurological disorders, obesity, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis
General Information
| Serial Number | 88554942 |
| Word Mark | VAIGHT |
| Filing Date | Wednesday, July 31, 2019 |
| Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
| Status Date | Monday, March 20, 2023 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, December 17, 2019 |
Trademark Statements
| Goods and Services | Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, headaches, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, neurodegenerative diseases and disorders, neurological disorders, obesity, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, August 15, 2019 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Eli Lilly and Company |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Indianapolis, IN 46285 |
| Party Name | Eli Lilly and Company |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Indianapolis, IN 46285 |
Trademark Events
| Event Date | Event Description |
| Monday, March 20, 2023 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| Monday, March 20, 2023 | ABANDONMENT - NO USE STATEMENT FILED |
| Tuesday, July 19, 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Monday, July 18, 2022 | SOU EXTENSION 5 GRANTED |
| Thursday, July 14, 2022 | SOU EXTENSION 5 FILED |
| Thursday, July 14, 2022 | SOU TEAS EXTENSION RECEIVED |
| Friday, January 14, 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, January 13, 2022 | SOU EXTENSION 4 GRANTED |
| Tuesday, January 11, 2022 | SOU EXTENSION 4 FILED |
| Tuesday, January 11, 2022 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, July 20, 2021 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Friday, July 16, 2021 | SOU EXTENSION 3 GRANTED |
| Friday, July 16, 2021 | SOU EXTENSION 3 FILED |
| Friday, July 16, 2021 | SOU TEAS EXTENSION RECEIVED |
| Friday, January 15, 2021 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Wednesday, January 13, 2021 | SOU EXTENSION 2 GRANTED |
| Wednesday, January 13, 2021 | SOU EXTENSION 2 FILED |
| Wednesday, January 13, 2021 | SOU TEAS EXTENSION RECEIVED |
| Saturday, August 8, 2020 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Friday, August 7, 2020 | SOU EXTENSION 1 GRANTED |
| Friday, July 10, 2020 | SOU EXTENSION 1 FILED |
| Thursday, August 6, 2020 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Friday, July 10, 2020 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, February 11, 2020 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, December 17, 2019 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, December 17, 2019 | PUBLISHED FOR OPPOSITION |
| Wednesday, November 27, 2019 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Sunday, November 10, 2019 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Saturday, October 26, 2019 | ASSIGNED TO EXAMINER |
| Thursday, August 15, 2019 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Saturday, August 3, 2019 | NEW APPLICATION ENTERED |
